Flavio Vincenti, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address505 Parnassus Avenue
San Francisco CA 94117
Phone415-353-1322
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine

    Collapse Overview 
    Collapse Overview
    I have been at UCSF since 1975 and on the faculty of the Department of Medicine in the division of Nephrology since 1976 and have been involved with the transplant service in patient care and clinical trials with novel immunosuppression drugs

    Collapse Research 
    Collapse Research Activities and Funding
    Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts
    NIH U01AI113362Jul 1, 2014 - Jun 30, 2021
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000079Dec 1, 1974 - Mar 31, 2009
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Comparison of Ex Vivo Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells. Front Immunol. 2021; 12:679675. Lee LM, Zhang H, Lee K, Liang H, Merleev A, Vincenti F, Maverakis E, Thomson AW, Tang Q. PMID: 34220826.
      View in: PubMed   Mentions:    Fields:    
    2. Tests for the noninvasive diagnosis of kidney transplant rejection should be evaluated by kidney transplant programs. Am J Transplant. 2021 Jun 03. Danovitch GM, Bunnapradist S, Cohen D, Hariharan S, McKay D, Ratner L, Stegall MD, Steiner RW, Stock PG, Vincenti F. PMID: 34080294.
      View in: PubMed   Mentions:    Fields:    
    3. Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial. Am J Transplant. 2021 Jul; 21(7):2543-2554. Chandran S, Leung J, Hu C, Laszik ZG, Tang Q, Vincenti FG. PMID: 33331082.
      View in: PubMed   Mentions: 1     Fields:    
    4. Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation. Front Genet. 2020; 11:610682. Zarinsefat A, Hartoularos G, Rychkov D, Rashmi P, Chandran S, Vincenti F, Yee CJ, Sarwal MM. PMID: 33469465.
      View in: PubMed   Mentions:
    5. Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients. Am J Transplant. 2021 05; 21(5):1691-1698. Kirk AD, Adams AB, Durrbach A, Ford ML, Hildeman DA, Larsen CP, Vincenti F, Wojciechowski D, Woodle ES. PMID: 33128812.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function. Kidney Int Rep. 2021 Feb; 6(2):296-303. Vincenti F, Kim J, Gouveia D, Pelle G, Mayne TJ, Neylan JF. PMID: 33615054.
      View in: PubMed   Mentions:
    7. The impact of belatacept on the phenotypic heterogeneity of renal T cell-mediated alloimmune response: The critical role of maintenance treatment and inflammatory load. Clin Transplant. 2020 11; 34(11):e14084. Dobi D, Vincenti F, Chandran S, Greenland JR, Bowman C, Chen A, Junger H, Laszik ZG. PMID: 32939817.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Single-cell RNA sequencing of Tocilizumab-treated peripheral blood mononuclear cells as an in vitro model of inflammation. bioRxiv. 2020 Sep 11. Zarinsefat A, Hartoularos G, Chandran S, Yee CJ, Vincenti F, Sarwal MM. PMID: 32935096.
      View in: PubMed   Mentions:
    9. A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection. Sci Transl Med. 2020 03 18; 12(535). Yang JYC, Sarwal RD, Sigdel TK, Damm I, Rosenbaum B, Liberto JM, Chan-On C, Arreola-Guerra JM, Alberu J, Vincenti F, Sarwal MM. PMID: 32188722.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    10. Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes. Transplantation. 2020 01; 104(1):54-60. Harel E, Shoji J, Abraham V, Miller L, Laszik ZG, King A, Dobi D, Szabo G, Hann B, Sarwal MM, Craik CS, Vincenti F. PMID: 31449183.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    11. Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies. Front Med (Lausanne). 2019; 6:213. Sigdel T, Nguyen M, Liberto J, Dobi D, Junger H, Vincenti F, Laszik Z, Sarwal MM. PMID: 31632976.
      View in: PubMed   Mentions:
    12. A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation. Am J Transplant. 2020 01; 20(1):172-180. Vincenti F, Klintmalm G, Yang H, Ram Peddi V, Blahunka P, Conkle A, Santos V, Holman J. PMID: 31397943.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    13. Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant. Am J Transplant. 2019 11; 19(11):3035-3045. Redfield RR, Jordan SC, Busque S, Vincenti F, Woodle ES, Desai N, Reed EF, Tremblay S, Zachary AA, Vo AA, Formica R, Schindler T, Tran H, Looney C, Jamois C, Green C, Morimoto A, Rajwanshi R, Schroeder A, Cascino MD, Brunetta P, Borie D. PMID: 31257724.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    14. Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients. Transplant Rev (Orlando). 2019 10; 33(4):191-199. Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-Silva H. PMID: 31377099.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study. Am J Transplant. 2019 11; 19(11):3018-3034. Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J, TRANSFORM investigators . PMID: 31152476.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    16. Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing. Nat Commun. 2019 04 23; 10(1):1906. Pineda S, Sigdel TK, Liberto JM, Vincenti F, Sirota M, Sarwal MM. PMID: 31015506.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    17. Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation. Clin Transplant. 2019 03; 33(3):e13487. Harel E, Shoji J, Abraham V, Miller L, Laszik Z, Thurison T, King A, Olshen A, Leung J, Szabo G, Hann B, Høyer-Hansen G, Craik CS, Vincenti F. PMID: 30689221.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial. Transplant Direct. 2018 Sep; 4(9):e380. Busque S, Vincenti FG, Tedesco Silva H, O'Connell PJ, Yoshida A, Friedewald JJ, Steinberg SM, Budde K, Broeders EN, Kim YS, Hahn CM, Li H, Chan G. PMID: 30234149.
      View in: PubMed   Mentions:
    19. Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial. Transplant Direct. 2018 Jul; 4(7):e369. Webber AB, Tatapudi V, Maw TT, Peralta C, Leung JCY, Vincenti F. PMID: 30046659.
      View in: PubMed   Mentions:
    20. A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor. Am J Transplant. 2018 12; 18(12):2945-2954. Vincenti F, Budde K, Merville P, Shihab F, Ram Peddi V, Shah M, Wyburn K, Cassuto-Viguier E, Weidemann A, Lee M, Flegel T, Erdman J, Wang X, Lademacher C. PMID: 29745007.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsCTClinical Trials
    21. Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation. J Am Soc Nephrol. 2018 07; 29(7):1979-1991. Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F, TRANSFORM Investigators . PMID: 29752413.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    22. Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT. Clin Transplant. 2018 04; 32(4):e13225. Florman S, Vincenti F, Durrbach A, Abouljoud M, Bresnahan B, Garcia VD, Mulloy L, Rice K, Rostaing L, Zayas C, Calderon K, Meier-Kriesche U, Polinsky M, Yang L, Medina Pestana J, Larsen CP. PMID: 29461660.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    23. Targeted Transcriptional Profiling of Kidney Transplant Biopsies. Kidney Int Rep. 2018 May; 3(3):722-731. Sigdel TK, Nguyen M, Dobi D, Hsieh SC, Liberto JM, Vincenti F, Sarwal MM, Laszik Z. PMID: 29854981.
      View in: PubMed   Mentions:
    24. Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experience. Clin Transplant. 2017 Sep; 31(9). Wojciechowski D, Chandran S, Yang JYC, Sarwal MM, Vincenti F. PMID: 28662293.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Transplant trials with Tregs: perils and promises. J Clin Invest. 2017 Jun 30; 127(7):2505-2512. Tang Q, Vincenti F. PMID: 28665300.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    26. A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis. Kidney Int Rep. 2017 Sep; 2(5):800-810. Vincenti F, Fervenza FC, Campbell KN, Diaz M, Gesualdo L, Nelson P, Praga M, Radhakrishnan J, Sellin L, Singh A, Thornley-Brown D, Veronese FV, Accomando B, Engstrand S, Ledbetter S, Lin J, Neylan J, Tumlin J, Focal Segmental Glomerulosclerosis Study Group . PMID: 29270487.
      View in: PubMed   Mentions:
    27. Belatacept: the challenges with transformational drugs. Transl Androl Urol. 2017 Apr; 6(2):341-342. Vincenti F. PMID: 28540252.
      View in: PubMed   Mentions:
    28. Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients. Clin Transplant. 2017 05; 31(5). Wojciechowski D, Chandran S, Vincenti F. PMID: 28190259.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    29. Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. Am J Kidney Dis. 2017 May; 69(5):587-594. Grinyó JM, Del Carmen Rial M, Alberu J, Steinberg SM, Manfro RC, Nainan G, Vincenti F, Jones-Burton C, Kamar N. PMID: 27889299.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    30. Current status of costimulatory blockade in renal transplantation. Curr Opin Nephrol Hypertens. 2016 11; 25(6):583-590. Wojciechowski D, Vincenti F. PMID: 27517137.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2. Adv Chronic Kidney Dis. 2016 09; 23(5):306-311. Wojciechowski D, Vincenti F. PMID: 27742385.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Belatacept and Long-Term Outcomes in Kidney Transplantation. N Engl J Med. 2016 06 30; 374(26):2600-1. Vincenti F. PMID: 27355541.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    33. An Update on Calcineurin Inhibitor-Free Regimens: The Need Persists, but the Landscape has Changed. Transplantation. 2016 Apr; 100(4):836-43. Webber AB, Vincenti F. PMID: 27003097.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    34. Belatacept and Long-Term Outcomes in Kidney Transplantation. N Engl J Med. 2016 Jan 28; 374(4):333-43. Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, Moal MC, Mondragon-Ramirez GA, Kothari J, Polinsky MS, Meier-Kriesche HU, Munier S, Larsen CP. PMID: 26816011.
      View in: PubMed   Mentions: 129     Fields:    Translation:HumansCTClinical Trials
    35. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation. Transplantation. 2016 Jan; 100(1):184-93. Wolf M, Weir MR, Kopyt N, Mannon RB, Von Visger J, Deng H, Yue S, Vincenti F. PMID: 26177089.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    36. A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts. PLoS One. 2015; 10(9):e0138133. Sigdel TK, Bestard O, Tran TQ, Hsieh SC, Roedder S, Damm I, Vincenti F, Sarwal MM. PMID: 26367000.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    37. The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS Med. 2014 Nov; 11(11):e1001759. Roedder S, Sigdel T, Salomonis N, Hsieh S, Dai H, Bestard O, Metes D, Zeevi A, Zeevi A, Gritsch A, Cheeseman J, Macedo C, Peddy R, Medeiros M, Vincenti F, Asher N, Salvatierra O, Shapiro R, Kirk A, Reed EF, Reed E, Sarwal MM. PMID: 25386950.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    38. Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol. 2014 Jul; 25(7):1415-29. Fiorina P, Vergani A, Bassi R, Niewczas MA, Altintas MM, Pezzolesi MG, D'Addio F, Chin M, Tezza S, Ben Nasr M, Mattinzoli D, Ikehata M, Corradi D, Schumacher V, Buvall L, Yu CC, Chang JM, La Rosa S, Finzi G, Solini A, Vincenti F, Rastaldi MP, Reiser J, Krolewski AS, Mundel PH, Sayegh MH. PMID: 24676639.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    39. Clinical aspects: focusing on key unique organ-specific issues of renal transplantation. Cold Spring Harb Perspect Med. 2014 Feb 01; 4(2). Chandran S, Vincenti F. PMID: 24370927.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Tofacitinib in kidney transplantation. Expert Opin Investig Drugs. 2013 Sep; 22(9):1193-9. Wojciechowski D, Vincenti F. PMID: 23841583.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    41. Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma. Transpl Int. 2013 Sep; 26(9):938-48. van Gelder T, Baan C, Vincenti F, Mannon RB. PMID: 23822608.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    42. Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scans. Transpl Int. 2013 May; 26(5):471-6. Vagefi PA, Qian JJ, Carlson DM, Aparici CM, Hirose R, Vincenti F, Wojciechowski D. PMID: 23384317.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    43. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year. Transplantation. 2012 Dec 15; 94(11):1117-23. Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F. PMID: 23060281.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    44. Belatacept in kidney transplantation. Curr Opin Organ Transplant. 2012 Dec; 17(6):640-7. Wojciechowski D, Vincenti F. PMID: 23044530.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    45. Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update. Biologics. 2012; 6:385-93. Wojciechowski D, Vincenti F. PMID: 23152668.
      View in: PubMed   Mentions:
    46. Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients. Transpl Int. 2012 Dec; 25(12):1257-67. Tang Q, Leung J, Melli K, Lay K, Chuu EL, Liu W, Bluestone JA, Kang SM, Peddi VR, Vincenti F. PMID: 22994802.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    47. Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study. Transpl Int. 2012 Oct; 25(10):1059-64. Grinyo J, Alberu J, Contieri FL, Manfro RC, Mondragon G, Nainan G, Rial Mdel C, Steinberg S, Vincenti F, Dong Y, Thomas D, Kamar N. PMID: 22816557.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    48. Are calcineurin inhibitors-free regimens ready for prime time? Kidney Int. 2012 Nov; 82(10):1054-60. Vincenti F. PMID: 22622502.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    49. Targeting JAK3 in kidney transplantation: current status and future options. Curr Opin Organ Transplant. 2011 Dec; 16(6):614-9. Wojciechowski D, Vincenti F. PMID: 21971513.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    50. C4d/CD34 double-immunofluorescence staining of renal allograft biopsies for assessing peritubular capillary C4d positivity. Mod Pathol. 2012 Mar; 25(3):434-8. Jen KY, Nguyen TB, Vincenti FG, Laszik ZG. PMID: 22037262.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2696-704. Rostaing L, Neumayer HH, Reyes-Acevedo R, Bresnahan B, Florman S, Vitko S, Heifets M, Xing J, Thomas D, Vincenti F. PMID: 21921152.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    52. Belatacept. Nat Rev Drug Discov. 2011 Aug 31; 10(9):655-6. Vincenti F, Dritselis A, Kirkpatrick P. PMID: 21878974.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    53. Challenges and opportunities in targeting the costimulation pathway in solid organ transplantation. Semin Immunol. 2011 Jun; 23(3):157-64. Wojciechowski D, Vincenti F. PMID: 21856169.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    54. Novel strategies in immunosuppression: issues in perspective. Transplantation. 2011 May 27; 91(10):1057-64. Webber A, Hirose R, Vincenti F. PMID: 21412186.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    55. Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies). Transplantation. 2011 May 15; 91(9):976-83. Vanrenterghem Y, Bresnahan B, Campistol J, Durrbach A, Grinyó J, Neumayer HH, Lang P, Larsen CP, Mancilla-Urrea E, Pestana JM, Block A, Duan T, Glicklich A, Gujrathi S, Vincenti F. PMID: 21372756.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    56. A phase 1, single-dose study of fresolimumab, an anti-TGF-ß antibody, in treatment-resistant primary focal segmental glomerulosclerosis. Kidney Int. 2011 Jun; 79(11):1236-43. Trachtman H, Fervenza FC, Gipson DS, Heering P, Jayne DR, Peters H, Rota S, Remuzzi G, Rump LC, Sellin LK, Heaton JP, Streisand JB, Hard ML, Ledbetter SR, Vincenti F. PMID: 21368745.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCTClinical Trials
    57. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation. 2010 Dec 27; 90(12):1595-601. Posselt AM, Szot GL, Frassetto LA, Masharani U, Tavakol M, Amin R, McElroy J, Ramos MD, Kerlan RK, Fong L, Vincenti F, Bluestone JA, Stock PG. PMID: 20978464.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    58. Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study. Transplantation. 2010 Dec 27; 90(12):1427-31. Humar A, Limaye AP, Blumberg EA, Hauser IA, Vincenti F, Jardine AG, Abramowicz D, Ives JA, Farhan M, Peeters P. PMID: 21197713.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    59. An integrated safety profile analysis of belatacept in kidney transplant recipients. Transplantation. 2010 Dec 27; 90(12):1521-7. Grinyó J, Charpentier B, Pestana JM, Vanrenterghem Y, Vincenti F, Reyes-Acevedo R, Apanovitch AM, Gujrathi S, Agarwal M, Thomas D, Larsen CP. PMID: 21088650.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    60. Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies. Transplantation. 2010 Dec 27; 90(12):1528-35. Larsen CP, Grinyó J, Medina-Pestana J, Vanrenterghem Y, Vincenti F, Breshahan B, Campistol JM, Florman S, Rial Mdel C, Kamar N, Block A, Di Russo G, Lin CS, Garg P, Charpentier B. PMID: 21076381.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    61. How the development of new biological agents may help minimize immunosuppression in kidney transplantation: the impact of belatacept. Curr Opin Organ Transplant. 2010 Dec; 15(6):697-702. Wojciechowski D, Vincenti F. PMID: 20930638.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study. Clin J Am Soc Nephrol. 2011 Feb; 6(2):430-9. Rostaing L, Massari P, Garcia VD, Mancilla-Urrea E, Nainan G, del Carmen Rial M, Steinberg S, Vincenti F, Shi R, Di Russo G, Thomas D, Grinyó J. PMID: 21051752.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    63. Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database. Am J Kidney Dis. 2010 Dec; 56(6):1127-39. Kuo HT, Sampaio MS, Vincenti F, Bunnapradist S. PMID: 20934793.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    64. Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol. 2010 Sep; 21(9):1587-96. Vincenti F, Blancho G, Durrbach A, Friend P, Grinyo J, Halloran PF, Klempnauer J, Lang P, Larsen CP, Mühlbacher F, Nashan B, Soulillou JP, Vanrenterghem Y, Wekerle T, Agarwal M, Gujrathi S, Shen J, Shi R, Townsend R, Charpentier B. PMID: 20634298.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    65. Kidney transplantation at UCSF: 8,300 transplants and onward. Clin Transpl. 2010; 161-7. Wojciechowski D, Hirose R, Stock P, Vincenti F, Baxter-Lowe LA, Salvatierra O. PMID: 21696039.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. Novel B cell therapeutic targets in transplantation and immune-mediated glomerular diseases. Clin J Am Soc Nephrol. 2010 Jan; 5(1):142-51. Vincenti F, Cohen SD, Appel G. PMID: 20007678.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    67. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010 Feb; 77(4):299-311. Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM, Kidney Disease: Improving Global Outcomes . PMID: 19847156.
      View in: PubMed   Mentions: 118     Fields:    Translation:Humans
    68. Kidney transplantation: the ideal immunosuppression regimen. Adv Chronic Kidney Dis. 2009 Jul; 16(4):226-33. Yabu JM, Vincenti F. PMID: 19576552.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    69. Transplantation: To convert or not to convert: lessons from the CONVERT trial. Nat Rev Nephrol. 2009 Jul; 5(7):371-3. Bunnapradist S, Vincenti F. PMID: 19556993.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    70. The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study. Transplantation. 2009 May 15; 87(9):1360-6. Ekberg H, Mamelok RD, Pearson TC, Vincenti F, Tedesco-Silva H, Daloze P. PMID: 19424036.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    71. Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol. 2009 Jul; 4(7):1230-8. Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM. PMID: 19443625.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    72. Evolving trends in induction therapy. Transplant Rev (Orlando). 2009 Apr; 23(2):94-102. Arias M, Campistol JM, Vincenti F. PMID: 19298940.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    73. Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation. Transplantation. 2009 Mar 27; 87(6):926-33. Latek R, Fleener C, Lamian V, Kulbokas E, Davis PM, Suchard SJ, Curran M, Vincenti F, Townsend R. PMID: 19300198.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    74. Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients. Clin Pharmacokinet. 2009; 48(5):329-41. Kuypers DR, Ekberg H, Grinyó J, Nashan B, Vincenti F, Snell P, Mamelok RD, Bouw RM. PMID: 19566116.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    75. Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int. 2008 Sep; 21(9):879-91. Grinyó J, Vanrenterghem Y, Nashan B, Vincenti F, Ekberg H, Lindpaintner K, Rashford M, Nasmyth-Miller C, Voulgari A, Spleiss O, Truman M, Essioux L. PMID: 18444945.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    76. Costimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol. 2008 Feb; 121(2):299-306; quiz 307-8. Vincenti F. PMID: 18269922.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    77. Proteomics of plasma and urine in primary nephrotic syndrome in children. Contrib Nephrol. 2008; 160:17-28. Candiano G, Musante L, Petretto A, Bruschi M, Santucci L, Urbani A, Scolari F, Gusmano R, Carraro M, Zennaro C, Vincenti F, Ghiggeri GM. PMID: 18401158.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    78. Novel immunosuppression: small molecules and biologics. Semin Nephrol. 2007 Jul; 27(4):479-86. Yabu JM, Vincenti F. PMID: 17616278.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    79. Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients. Br J Clin Pharmacol. 2007 Dec; 64(6):758-71. Pescovitz MD, Vincenti F, Hart M, Melton L, Whelchel J, Mulgaonkar S, McKay D, Leung M, Calleja E, Bouw MR. PMID: 17555465.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    80. Costimulation blockade--what will the future bring? Nephrol Dial Transplant. 2007 May; 22(5):1293-6. Vincenti F. PMID: 17460033.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    81. Sirolimus: defining nephrotoxicity in the renal transplant recipient. Clin J Am Soc Nephrol. 2007 Mar; 2(2):198-9. Tomlanovich SJ, Vincenti F. PMID: 17699406.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    82. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J Am Soc Nephrol. 2007 Mar; 18(3):799-810. Musante L, Candiano G, Petretto A, Bruschi M, Dimasi N, Caridi G, Pavone B, Del Boccio P, Galliano M, Urbani A, Scolari F, Vincenti F, Ghiggeri GM. PMID: 17287427.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    83. T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation. Annu Rev Med. 2007; 58:347-58. Vincenti F, Luggen M. PMID: 17020493.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    84. Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature. Transplantation. 2006 Oct 27; 82(8):1004-12. Arns W, Cibrik DM, Walker RG, Mourad G, Budde K, Mueller EA, Vincenti F. PMID: 17060847.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    85. Immunosuppression: today, tomorrow, and withdrawal. Semin Liver Dis. 2006 Aug; 26(3):201-10. Hirose R, Vincenti F. PMID: 16850369.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    86. Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients. Transpl Int. 2006 Jun; 19(6):446-57. Vincenti F, de Andrés A, Becker T, Choukroun G, Cole E, González-Posada JM, Kumar MA, Moore R, Nadalin S, Nashan B, Rostaing L, Saito K, Yoshimura N. PMID: 16771865.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    87. Antibodies come back to the forefront in transplantation. Clin J Am Soc Nephrol. 2006 May; 1(3):399. Vincenti F. PMID: 17699237.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    88. Arsenite pre-conditioning reduces UVB-induced apoptosis in corneal epithelial cells through the anti-apoptotic activity of 27 kDa heat shock protein (HSP27). J Cell Physiol. 2006 Feb; 206(2):301-8. Shi B, Isseroff RR. PMID: 16120857.
      View in: PubMed   Mentions: 209     Fields:    Translation:HumansCellsCTClinical Trials
    89. A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients. Transplantation. 2005 Oct 15; 80(7):910-6. Vincenti F, Mendez R, Curtis J, Light J, Pearson T, Wu YM, Katz SM, Akalin E, Esterl R, Gugliuzza K, Shihab F, Jordan S, Jonsson J, Molmenti E, Barbeito R. PMID: 16249738.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    90. Toxicity-sparing protocols using mycophenolate mofetil in renal transplantation. Transplantation. 2005 Oct 15; 80(2 Suppl):S221-34. Land W, Vincenti F. PMID: 16251855.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    91. Rapidly developing nephrocalcinosis in a patient with end-stage liver disease who received a domino liver transplant from a patient with known congenital oxalosis. J Ultrasound Med. 2005 Oct; 24(10):1449-52. Aziz S, Callen PW, Vincenti F, Hirose R. PMID: 16179633.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    92. Current use and future trends in induction therapy. Saudi J Kidney Dis Transpl. 2005 Oct-Dec; 16(4):506-13. Vincenti F. PMID: 18202505.
      View in: PubMed   Mentions: 2     Fields:    
    93. A drug of the past, a lesson for the future. Pediatr Transplant. 2005 Jun; 9(3):267-8. Vincenti F. PMID: 15910379.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    94. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant. 2005 Jun; 19(3):291-8. Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, Jardine A, Levitt N, Marchetti P, Markell M, Naicker S, O'Connell P, Schnitzler M, Standl E, Torregosa JV, Uchida K, Valantine H, Villamil F, Vincenti F, Wissing M. PMID: 15877787.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    95. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant. 2005 Jun; 5(6):1179-85. Vincenti F, Ghiggeri GM. PMID: 15888021.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    96. An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency. Clin Transplant. 2005 Feb; 19(1):130-6. Peddi VR, Jensik S, Pescovitz M, Pirsch J, Adler SH, Thistlethwaite JR, Vincenti F, Cohen DJ. PMID: 15659146.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    97. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation. Contemp Clin Trials. 2005 Feb; 26(1):17-24. Vincenti F, Rostaing L, DIRECT (Diabetes Incidence after REnal Transplantation: Neoral C2 monitoring versus Tacrolimus) inve . PMID: 15837449.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    98. A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. Am J Transplant. 2005 Jan; 5(1):157-66. Woodle ES, Vincenti F, Lorber MI, Gritsch HA, Hricik D, Washburn K, Matas AJ, Gallichio M, Neylan J. PMID: 15636625.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    99. Chronic induction. What's new in the pipeline. Contrib Nephrol. 2005; 146:22-29. Vincenti F. PMID: 15567917.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen. Am J Transplant. 2004 Dec; 4(12):2132-4. Lipshutz GS, Flechner SM, Govani MV, Vincenti F. PMID: 15575919.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    101. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients. Transpl Int. 2004 Sep; 17(8):395-401. Vincenti F. PMID: 15365604.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    102. A decade of progress in kidney transplantation. Transplantation. 2004 May 15; 77(9 Suppl):S52-61. Vincenti F. PMID: 15201687.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    103. Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy. Nephrol Dial Transplant. 2004 May; 19(5):1036-40. Ghiggeri GM, Carraro M, Vincenti F. PMID: 15004256.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    104. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation. 2004 Jan 15; 77(1):131-3. Ramos E, Vincenti F, Lu WX, Shapiro R, Trofe J, Stratta RJ, Jonsson J, Randhawa PS, Drachenberg CB, Papadimitriou JC, Weir MR, Wali RK. PMID: 14724448.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    105. Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation. Clin Transplant. 2003 Dec; 17(6):511-7. Pescovitz MD, Bumgardner G, Gaston RS, Kirkman RL, Light S, Patel IH, Nieforth K, Vincenti F. PMID: 14756266.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    106. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients. Transplantation. 2003 Jul 15; 76(1):190-5. Posselt AM, Vincenti F, Bedolli M, Lantz M, Roberts JP, Hirose R. PMID: 12865808.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    107. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant. 2003 Jul; 3(7):835-45. Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F. PMID: 12814475.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    108. Immunosuppression minimization: current and future trends in transplant immunosuppression. J Am Soc Nephrol. 2003 Jul; 14(7):1940-8. Vincenti F. PMID: 12819255.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    109. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant. 2003 Mar; 3(3):306-11. Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A. PMID: 12614286.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    110. Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation. Am J Transplant. 2003 Jan; 3(1):50-2. Vincenti F, Pace D, Birnbaum J, Lantz M. PMID: 12492710.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    111. What's in the pipeline? New immunosuppressive drugs in transplantation. Am J Transplant. 2002 Nov; 2(10):898-903. Vincenti F. PMID: 12482141.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    112. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation. 2002 Mar 15; 73(5):775-82. Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J. PMID: 11907427.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    113. Effect of calcineurin inhibitor therapy on P-gp expression and function in lymphocytes of renal transplant patients: a preliminary evaluation. J Clin Pharmacol. 2002 Mar; 42(3):304-11. Parasrampuria DA, Lantz MV, Birnbaum JL, Vincenti FG, Benet LZ. PMID: 11865967.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    Flavio's Networks
    Concepts (340)
    Derived automatically from this person's publications.
    _
    Co-Authors (42)
    People in Profiles who have published with this person.
    _
    Similar People (59)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _